Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

19 toradh

  1. SCIENCE|natural and applied sciences|life sciences|biology · SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|medicament|antibiotic

    #618705

    IATE #1098823
    antaibheathach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Antibiotikum
    de
    Sainmhíniú natürlich gebildetes, niedermolekulares Stoffwechselprodukt von Pilzen oder Bakterien, das schon in geringer Konzentration das Wachstum von anderen Mikroorganismen hemmt oder diese abtötet Tagairt "Wikipedia, http://de.wikipedia.org/wiki/Antibiotikum (1.3.2010)"
    Nóta "gehört zu den antimikrobiellen Wirkstoffen IATE:834434 ; XREF: antimikrobielle Resistenz IATE:912591 ; Antibiotika-Resistenz IATE:1073649"
    antibiotic
    en
    Sainmhíniú substance produced by, or derived (chemically produced) from a micro-organism that selectively destroys or inhibits the growth of other micro-organisms Tagairt "European Centre for Disease prevention and Control (ECDC), EFSA, European Medicines Agency (EMEA), Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Joint Opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA; 2009, http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/1372.pdf [14.3.2018]"
    Nóta "Antibiotics belong to the broader group of antimicrobial compounds used to treat infections caused by microorganisms including fungi and protozoa. Technically, 'antibiotic' refers only to antimicrobials (IATE:834434 ) derived from bacteria or molds. See also: - antibacterial (broader) IATE:1686932 - systemic antibiotic (narrower) IATE:3517064 - antimicrobial (broader) IATE:834434"
  2. SOCIAL QUESTIONS|health|medical science

    #648811

    IATE #3544052
    cúngú antaibheathach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Deeskalationstherapie
    de
    Sainmhíniú Ersetzung der anfänglichen, kalkulierten Breitbandantibiotikagabe durch ein Antbiotikum mit gezieltem schmalem Wirkungsspektrum, sobald Erreger und Antibiogramm bekannt sind, um so Resistenzen zu vermeiden Tagairt "Council-DE vgl. Das Zweite Kompakt, K.P. Schaps, O. Kessler, U. Fetzner, Galer-Wissenschaftsverlage http://books.google.de/books?id=YeHdRKliIEgC&pg=PA88&lpg=PA88&dq=breitbandantibiotikum+deeskalation&source=bl&ots=5snT52eRuQ&sig=A0T8hr57UeCxO5Fih4combLFLOE&hl=de&sa=X&ei=NQDPT-nzEsfT8gOvtMS7DA&ved=0CF0Q6AEwAg#v=onepage&q=breitbandantibiotikum%20deeskalation&f=false (6.6.2012)"
    Nóta DIV: aih, 6.6.2012
    antibiotic de-escalation | de-escalation | de-escalation therapy
    en
    Sainmhíniú initial use of wide-spectrum antimicrobials followed by a reassessment of treatment once culture test results are available Tagairt "COM-EN, based on:Garnacho-Montero J, Escoresca-Ortega A, Fernández-Delgado E. 'Antibiotic de-escalation in the ICU: how is it best done?' Curr Opin Infect Dis. 2015 Apr;28(2):193-8, https://www.ncbi.nlm.nih.gov/pubmed/25692272 [20.3.2018]"
    désescalade antibiotique | désescalade thérapeuthique | désescalade
    fr
    Sainmhíniú remplacement d'une antibiothérapie probabiliste à large spectre par une antibiothérapie au spectre plus étroit, chez un patient dont l'état s'est amélioré grâce à l'antibiothérapie initiale, afin d'assurer l'adéquation de l'antibiothérapie initiale et de diminuer le risque d'émergence de germes multirésistants Tagairt "Conseil-FR, ea d'après Dr A. Meybeck, Service de réanimation et maladies infectieuses, ""La désescalade antibiotique en réanimation"", http://www.armeda.fr/index.php?option=com_docman&task=doc_view&gid=27&Itemid=56 (5.6.21012)"
  3. SOCIAL QUESTIONS|health · SOCIAL QUESTIONS|health|medical science

    #617664

    IATE #1073649
    frithsheasmhacht in aghaidh antaibheathach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Antibiotikaresistenz | antibiotische Resistenz
    de
    Sainmhíniú "Unempfindlichkeit von Bakterien gegen ein bestimmtes Antibiotikum IATE:1098823" Tagairt "Council-DE nach RKI > Infektionsschutz > Antibiotikaresistenz > Grundwissen Antibiotikaresistenz (4.9.2020)"
    Nóta "siehe auch antimikrobielle Resistenz /all"" id=""ENTRY_TO_ENTRY_CONVERTER"" target=""_blank"">IATE:3573244>;;;;;;;; und IATE:912591"
    antibiotic resistance | resistance to antibiotics
    en
    Sainmhíniú resistance occurring when bacteria develop the ability to defeat the drugs designed to kill them, the consequence of which is that antibiotics cannot fight them, and the bacteria multiply Tagairt "EP-Terminology Coordination, based on: Center for Disease Control and Prevention, CDC > Antibiotic Use > Appropriate Antibiotic Use: Community > About, ’Antibiotic Resistance Questions and Answers’, https://www.cdc.gov/drugresistance/about.html [6.10.2018]"
    Nóta "Antibiotic resistance occurs when bacteria change in response to the use of antibiotics used to treat bacterial infections (such as urinary tract infections, pneumonia, bloodstream infections) making them ineffective. Antibiotics fight bacteria, not viruses.Antimicrobial resistance is a broader term, encompassing resistance to drugs that treat infections caused by other microbes as well, such as parasites (e.g. malaria or helminths), viruses (e.g. HIV) and fungi (e.g. Candida).References: - World Health Organization, ’What is the difference between antibiotic and antimicrobial resistance?’, http://www.emro.who.int/health-topics/drug-resistance/what-is-the-difference-between-antibiotic-and-antimicrobial-resistance.html [6.11.2018] - U. S. Food and Drug Administration, Home For Consumers > Consumer Updates, ‘Combating Antibiotic Resistance’, 15 November 2011, https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm092810.htm [6.11.2018] "
    résistance aux antibiotiques | antibiorésistance
    fr
  4. SOCIAL QUESTIONS|health|medical science

    #636175

    IATE #1878455
    géin frithsheasta in aghaidh antaibheathach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Antibiotikaresistenz-Gen
    de
    antibiotic resistance gene | antibiotic-resistance gene | antibiotic resistance marker gene
    en
    Sainmhíniú gene encoding an enzyme that degrades a specific antibiotic to harmless byproducts, protecting its possessor from the lethal effects of the chemical Tagairt GE and Antibiotic Resistance, 2001, GEO-PIE Project, Cornell University
    Nóta "For antibiotic restistance marker gene, see IATE:318352"
    gène de résistance aux antibiotiques
    fr
  6. AGRI-FOODSTUFFS|plant product · PRODUCTION, TECHNOLOGY AND RESEARCH|technology and technical regulations|technology

    #603263

    IATE #318352
    suaitheantas géiniteach atá frithsheasmhach in aghaidh antaibheathach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Antibiotikaresistenz-Markergen | ARMG
    de
    antibiotic resistance marker gene | ARM gene
    en
    Sainmhíniú "gene providing resistance to an antibiotic and inserted into recombinant-DNA plants [IATE:3541756] as marker [IATE:1096547 ], which is linked to the new gene with a desirable trait" Tagairt "UK Food Standards Agency. The use of antibiotic resistance marker genes in GM plants http://www.food.gov.uk/multimedia/pdfs/acnfparmsfactsheet.pdf [6.3.2012]"
    Nóta Scientists can then use this marker to select the insertion of the new gene. In some GM crop varieties, antibiotic resistance genes are used at an earlier stage in the process, when genes are being assembled for insertion into the plant. This is normally done using microorganisms but the resistance gene may then be carried through the process so that it is present in the GM plants.
    gène marqueur de résistance aux antibiotiques | gène marqueur de la résistance aux antibiotiques
    fr
    Sainmhíniú gène (généralement d’origine bactérienne) utilisé comme marqueur de sélection en transgenèse, car sa présence permet la survie des cellules en présence d’agents antibiotiques normalement toxiques Tagairt "D'après: Glossaire FAO, http://www.fao.org/glossary/spec-term-n.asp?id_glo=5113&id_lang=TERMS_F [30.7.2013]"
    Nóta "Ces gènes étaient utilisés dans le développement et la libération de la première génération d’organismes transgéniques (particulièrement chez les plantes cultivées), mais ils ne sont plus recommandés à cause des risques potentiels associés au transfert indésiré de la résistance aux antibiotiques à d’autres organismes.Source: Glossaire FAO, http://www.fao.org/glossary/spec-term-n.asp?id_glo=5113&id_lang=TERMS_F [30.7.2013]"
  7. SCIENCE|natural and applied sciences|life sciences

    #617610

    IATE #1073505
    R-phlasmaid Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Resistenzfaktor | R-Faktor | R-Plasmid | Resistenzplasmid | Chemikalienresistenzplasmid | Antibiotikum-Resistenz-Plasmid
    de
    Sainmhíniú Plasmide (Resistenzplasmide), auf denen Gene der Antibiotika-Resistenz oder allgemein der Resistenz gegenüber antimikrobiellen Agenzien lokalisiert sind, die dem Plasmid-Träger die entsprechende Resistenz verleihen Tagairt "Lexikon der Biologie. Spektrum Akademischer Verlag: Heidelberg, 1999, s. v. „Resistenzfaktoren“, http://www.spektrum.de/lexikon/biologie/resistenzfaktoren/56364 (25.10.2017)"
    resistance factor | R-factor | R factor | drug-resistance factor | R-factor plasmid | plasmids | resistance plasmid | R-plasmid | antibiotic resistance plasmid
    en
    Sainmhíniú "plasmid [ IATE:1684610 ] that carries and transmits genes responsible for resistance to antibiotics from one bacterium to another" Tagairt "The Free Dictionary http://www.thefreedictionary.com/R+factor [23.9.2010]"
    facteur de résistance | plasmide de résistance | facteur R | facteur de transfert de résistance
    fr
    Sainmhíniú Plasmide capable de transférer d'une bactérie à l'autre la résistance bactérienne aux antibiotiques. Tagairt Biofutur 5/86,p.24
  8. SCIENCE|natural and applied sciences|life sciences|biology|microorganism · SOCIAL QUESTIONS|health|pharmaceutical industry · SOCIAL QUESTIONS|health|medical science|therapeutics|antimicrobial resistance

    #655111

    IATE #3567815
    baictéar frithsheasmhach in aghaidh drugaí Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    baictéar frithsheasmhach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comhthéacs 'Is gá sonraí a sholáthar maidir le teacht chun cinn féideartha baictéar frithsheasmhach nó deitéarmanant frithsheasmhachta atá ábhartha do shláinte an duine agus a bhaineann le húsáid táirgí íocshláinte tréidliachta i gcás na dtáirgí sin.' Tagairt "Rialachán Tarmligthe (AE) 2021/805 lena leasaítear Iarscríbhinn II a ghabhann le Rialachán (AE) 2019/6 ó Pharlaimint na hEorpa agus ón gComhairle, CELEX:32021R0805/GA"
    antimicrobial-resistant bacterium | antibiotic-resistant bacterium | antimicrobial-resistant bacteria | antibiotic-resistant bacteria | antibiotic-resistant isolate | drug resistant bacterium | resistant bacterium | drug resistant bacteria | resistant bacteria
    en
    Sainmhíniú bacterial strain that has developed (acquired) resistance to at least one antimicrobial agent in a category Tagairt "COM-Terminology Coordination, based on:A.-P. Magiorakos, A. Srinivasan, R. B. Carey, Y. Carmeli, M. E. Falagas, C. G. Giske, S. Harbarth, J. F. Hindler, G. Kahlmeter, B. Olsson-Liljequist, D. L. Paterson, L. B. Rice, J. Stelling, M. J. Struelens, A. Vatopoulos, J. T. Weber and D. L. Monnet. 'Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance' (25.5.2023). Clinical Microbiology and Infection 2012; 18: 268–281. ©2011 European Society of Clinical Microbiology and Infectious Diseases"
    Nóta "See also: - acquired antimicrobial resistance- multidrug-resistant bacterium- extensively drug-resistant bacterium- pandrug-resistant bacterium"
  9. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|medicament|antibiotic

    #634618

    IATE #1687055
    antaibheathach béitealachtaim Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Betalaktam-Antibiotikum | Beta-Lactam-Antibiotikum Betalactam-Antibiotikum Betalaktamantibiotikum
    de
    Sainmhíniú Antibiotikum mit einem Betalaktam-Ring Tagairt "COM-DE gestützt auf Medizinlexikon Flexikon > Beta-Laktam-Antibiotikum, http://flexikon.doccheck.com/de/Beta-Laktam-Antibiotikum (30.8.2017)"
    beta-lactam antibiotic | β-lactam antibiotic | beta-lactam
    en
    Sainmhíniú "any antibiotic [ IATE:1098823 ] which has a β-lactam ring [ IATE:1141310 ] in its molecular structure" Tagairt "COM-EN, based on: Wikipedia http://en.wikipedia.org/wiki/Beta-lactam_antibiotic [20.3.2018]"
    Nóta "The classes of β-lactam antibiotics include: penicillins [ IATE:1450504 ], cephalosporins [ IATE:1361346 ], monobactams [ IATE:1453308 ] and carbapenems [ IATE:3536654 ]. All have a four-membered beta-lactam ring as part of their molecular structure. Beta-lactam antibiotics function by interfering with the growth of the cell walls of multiplying bacteria. Bacteria become resistant to these antibiotics by producing beta-lactamases, enzymes (such as penicillinase) that disrupt the beta-lactam ring. To counteract this, beta-lactamase inhibitors (e.g. clavulanic acid) may be added to beta-lactam antibiotics. For example, co-amoxiclav (Augmentin) is a mixture of amoxicillin and clavulanic acid.Note reference:: 'beta-lactam antibiotic' Concise Medical Dictionary. Oxford University Press (OUP), 2010. Oxford Reference Online, http://www.oxfordreference.com/view/10.1093/acref/9780199557141.001.0001/acref-9780199557141-e-11169?rskey=nJWZWT&result=1131 [20.3.2018]"
  10. SOCIAL QUESTIONS|health|pharmaceutical industry

    #643821

    IATE #3517476
    brisphointe cliniciúil Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    tiúchan antaibheathach an bhrisphointe Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Grenzkonzentration | Break-Point
    de
    breakpoint | breakpoints | breakpoint antibiotic concentration | concentrations | clinical breakpoint
    en
    Sainmhíniú discriminating concentration used in the interpretation of results of susceptibility testing to define isolates as susceptible, intermediate or resistant Tagairt "British Society for Antimicrobial Chemotherapy (BSAC) website > Alasdair P. MacGowana and Richard Wise. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests, http://bsac.org.uk/wp-content/uploads/2012/02/Chapter-3-Establishing-MIC-bps-2005updated.pdf [9.3.2010]"
    Nóta "These concentrations range from x mg/L (low) to y mg/L (high) and an isolate is characterised as:- susceptible (S), if at a concentration < less than x mg/L there is a high likelihood of therapeutic success- intermediate (I), if at a concentration more than x and less than y mg/L the therapeutic effect is uncertain, and- resistant (R), if at a concentration more than y mg/L there a high likelihood of therapeutic failure.For more information, see also: EUCAST definitions of clinical breakpoints and epidemiological cut-off values, http://www.srga.org/Eucastwt/eucastdefinitions.htm [22.11.2013]"
    valeur seuil | concentration critique
    fr
    Sainmhíniú valeur numérique utilisée pour restituer qualitativement les résultats d'un antibiogramme en deux ou trois catégories cliniques: sensible, intermédiaire, résistant Tagairt "COM-FR, d'après:Définitions de la résistance aux antibiotiques en médecine vétérinaire: épidémiologique ou pronostique, P. Sanders et M. Laurentie, http://documents.irevues.inist.fr/bitstream/handle/2042/48416/AVF_2012_3_261.pdf?sequence=1 [18.3.2015]"
  11. SOCIAL QUESTIONS|health|medical science|therapeutics|antimicrobial resistance · POLITICS|politics and public safety|public opinion|public awareness campaign

    #641295

    IATE #3500715
    Lá Feasachta Eorpach maidir le hÚsáid Antaibheathach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comhthéacs 'Gach bliain, ar ócáid Lá Feasachta Eorpach maidir le hÚsáid Antaibheathach, déanfaidh saineolaithe ó ECDC, an Coimisiún Eorpach, Oifig Réigiúnach don Eoraip de chuid na hEagraíochta Domhanda Sláinte, gníomhaireachtaí Eorpacha agus comhpháirtithe eile comhrá Twitter a reáchtáil le ceisteanna ar fhrithsheasmhacht in aghaidh antaibheathach a fhreagairt.' Tagairt "'Lá Feasachta Antaibheathaigh na hEorpa', An Lárionad Eorpach um Chosc agus Rialú Galar, http://ecdc.europa.eu/ga/eaad/antibiotics-get-involved/twitter-chats/Pages/twitter-chats.aspx [31.3.2016]"
    EAAD Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Europäischer Tag der Sensibilisierung für Antibiotikaresistenz
    de
    European Antibiotic Awareness Day | EAAD
    en
    Sainmhíniú annual European public health initiative that takes place on 18 November to raise awareness about the threat to public health of antibiotic resistance and the importance of prudent antibiotic us Tagairt "European Centre for Disease Prevention and Control (ECDC) > European Antibiotic Awareness Day > About (19.11.2019)."
    Journée européenne de sensibilisation au bon usage des antibiotiques | Journée européenne de sensibilisation à l'usage des antibiotiques | Journée européenne d'information sur les antibiotiques
    fr
  12. SOCIAL QUESTIONS|health|pharmaceutical industry

    #615438

    IATE #925937
    an Tionscadal Eorpach um Fhaireachas ar Thomhailt Ábhar Frithmhiocróbach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    ESAC Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Europäisches Netz zur Überwachung des Verbrauchs antimikrobieller Mittel | ESAC-Netz | Europäische Überwachung des Verbrauchs antimikrobieller Mittel | ESAC | Europäische Überwachung des Antibiotikaverbrauchs
    de
    Sainmhíniú europäisches Netz nationaler Überwachungssysteme, in dessen Rahmen Daten über den Gebrauch antimikrobieller Mittel in 34 Ländern Europas (darunter 27 EU-Mitgliedstaaten) erhoben werden Tagairt "Council-DE vgl. WHO http://www.euro.who.int/de/media-centre/sections/press-releases/2011/11/antibiotic-resistance-what-is-not-measured,-is-not-done.-surveillance-to-be-strengthened-throughout-europe (18.1.2018)"
    Nóta "XREF: European Antimicrobial Resistance Surveillance Network IATE:912579"
    European Surveillance of Antimicrobial Consumption Network | ESAC-Net | ESAC | European Surveillance of Antimicrobial Consumption | European Surveillance of Antibiotic Consumption
    en
    Sainmhíniú Europe-wide network of national surveillance systems, providing European reference data on antimicrobial consumption Tagairt "European Centre for Disease Prevention and Control, https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/esac-net-about [14/1/2018]"
    Nóta ESAC-Net collects and analyses data on antimicrobial consumption from EU and EEA/EFTA countries, both in the community and in the hospital sector. The collected data are used to provide timely information and feedback to EU and EEA/EFTA countries on indicators of antimicrobial consumption.
    réseau européen de surveillance de la consommation d'antimicrobiens | ESAC-net | projet européen de surveillance de la consommation d'antimicrobiens | ESAC | surveillance européenne de la consommation d'antibiotiques
    fr
    Sainmhíniú réseau européen des systèmes de surveillance nationaux chargé de fournir des données de référence européennes sur la consommation d'antimicrobiens Tagairt "Conseil-FR, d'après le site du Centre européen de prévention et de contrôle des maladies (en anglais), https://ecdc.europa.eu/en/about-us/partnerships-and-networks/disease-and-laboratory-networks/esac-net-about [19.1.2018]"
  13. SOCIAL QUESTIONS · SOCIAL QUESTIONS|health

    #661137

    IATE #3581462
    an Chomhpháirtíocht Dhomhanda um Thaighde agus Forbairt Antaibheathach Tagairt "Na chéad chéimeanna eile i dtreo an tAontas a bheith ina réigiún dea-chleachtais i ndáil leis an bhfrithsheasmhacht in aghaidh ábhair fhrithmhiocróbacha a chomhrac - Conclúidí ón gComhairle (14 Meitheamh 2019)"
    ga
    GARDP Tagairt Comhairle-GA
    ga
    Globale Partnerschaft für Antibiotikaforschung und -entwicklung | GARDP
    de
    Sainmhíniú von der WHO und der DNDi (Drugs for Neglected Diseases intitiative) gegründete öffentlich-private Partnerschaft zur Verwirklichung von FuE-Projekten im Bereich Antibiotika Tagairt "Deutsches Ärzteblatt > News > Politik > Entwicklung von Antibiotika für Pharmaunternehmen wenig lukrativ (23.1.2020)"
    Nóta Hintergrund der Initiative ist der Rückzug der Pharmaindustrie aus der Antibiotikaforschung wegen fehlender Wirtschaftlichkeit.
    Global Antibiotic Research and Development Partnership | GARDP
    en
    Sainmhíniú not-for-profit research and development organisation that addresses global public health needs by developing and delivering new or improved antibiotic treatments, while endeavouring to ensure their sustainable access Tagairt "GARDP website (16.7.2019)"
    Partenariat mondial pour la recherche-développement d’antibiotiques | Partenariat mondial pour la recherche et le développement en matière d’antibiotiques | GARDP | Partenariat mondial pour la recherche-développement de nouveaux antibiotiques | Partenariat mondial sur la recherche-développement en matière d’antibiotiques
    fr
    Sainmhíniú "initiative commune de l'OMS et de l'Initiative sur les médicaments pour les maladies négligées (DNDi) destinée à favoriser la recherche-développement dans le cadre de partenariats public-privé" Tagairt "Site de l'OMS (15 février 2018), Résistance aux antimicrobiens (12.7.2019)"
    Nóta "Cette initiative conjointe vise à mettre au point de nouveaux traitements antibiotiques, grâce à l'amélioration des antibiotiques existants et à la mise plus rapide sur le marché de nouveaux antibiotiques, à promouvoir leur utilisation responsable et à assurer un accès équitable à ces antibiotiques. Elle a pour objectif d'identifier en collaboration avec l'OMS les lacunes dans le domaine de la recherche-développement et de lancer des projets pour les combler."
  14. SOCIAL QUESTIONS|health|pharmaceutical industry

    #650455

    IATE #3550057
    cógas iarphaitinne Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Comhthéacs 'Mar gheall ar chlistí sa mhargadh in earnáil na cógaisaíochta, is baolach nach mbeidh rochtain i gcónaí ag othair ar chógais thábhachtacha toisc praghsanna fíor-arda, toisc aistarraingt cógas iarphaitinne agus toisc nach gcuirtear gach táirge nua ar na margaí náisiúnta uile i gcónaí.' Tagairt "'An Chomhairle um Fhostaíocht, Beartas Sóisialta, Sláinte agus Gnóthaí Tomhaltóirí, 16-17/06/2016,' Comhairle an Aontais Eorpaigh, https://www.consilium.europa.eu/ga/meetings/epsco/2016/06/16-17/ [17.1.2019]"
    patentfreies Arzneimittel
    de
    off-patent medicinal product | off-patent medicine | off-patent drug | off-patent antibiotics
    en
    Sainmhíniú "drug no longer protected by patent or any supplementary protection certificate" Tagairt "COM-Terminology Coordination, based on:Merck Manual > Drugs > Trade-Name and Generic Drugs > Overview of generic drugs and drug naming (15.5.2020)"
    Nóta "Not to be confused with generic drug.Not all off-patent drugs have generic versions. Sometimes a drug is too hard to duplicate, or adequate tests are not available to prove that the generic drug acts the same as the trade-name drug. Sometimes the market for the drug is so small that producing another version does not make good business sense. See also:- branded generic (narrower)"
    médicament non protégé par un brevet | médicament dont le brevet est arrivé à expiration | médicament dont le brevet est arrivé à échéance
    fr
    Sainmhíniú "médicament dont le brevet a expiré ou qui n'est plus protégé par un certificat complémentaire de protection [ IATE:1268236 ]" Tagairt COM-FR, d'après diverses sources.
    Nóta "Ne pas confondre avec médicament générique [ IATE:766172 ]"
  15. SOCIAL QUESTIONS|health|pharmaceutical industry

    #648872

    IATE #3544262
    antaibheathach cúltaca Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    reserve antibiotic
    en
    Sainmhíniú antibiotics and antibiotic classes that should be reserved for treatment of confirmed or suspected infections due to multi-drug-resistant organisms and should be treated as “last resort” options Tagairt "EP-Terminology Coordination, based on:WHO > Antibiotics groups > Reserve group (29.6.2023)"
  16. SOCIAL QUESTIONS|health|medical science

    #658339

    IATE #3573249
    tuairisciú roghnaitheach ar thorthaí micribhitheolaíochta Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    selektive Berichterstattung
    de
    selective reporting | selective reporting of antibiotic susceptibility data | selective reporting of microbiology results
    en
    Sainmhíniú strategy used in many microbiology laboratories to avoid the use of broad-spectrum agents and guide clinicians in the selection of antimicrobials, by only including identification and susceptibility results for clinically significant organisms in reports Tagairt "COM-EN, based on:- Lilian M. Abbo and Thomas M. Hooton. 'Antimicrobial Stewardship and Urinary Tract Infections' (28.6.2022). Antibiotics 2014, 3(2), 174-192.- Kerry LaPlante, Cheston Cunha, Haley Morrill, Louis Rice, Eleftherios Mylonakis. Antimicrobial Stewardship: Principles and Practice (28.6.2022). CABI, 2016."
  17. SOCIAL QUESTIONS|health|pharmaceutical industry

    #643732

    IATE #3517064
    antaibheathach sistéamach Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    systemisches Antibiotikum
    de
    systemic antibiotic
    en
    Sainmhíniú "antibiotic ( IATE:1098823 ) administered orally or parenterally and not locally" Tagairt "COM-EN based on: Antibiotics for treating chronic osteomyelitis in adults, Database of Systematic Reviews 2009, Issue 3. Art. No.: CD004439. L.O. Conterno, C.R. da Silva Filho, http://www2.cochrane.org/reviews/en/ab004439.html [18.3.2010]"
    antibiotique systémique | antibiotique administré par voie générale
    fr
  18. SOCIAL QUESTIONS|health|health policy · SOCIAL QUESTIONS|health|medical science|therapeutics|antimicrobial resistance

    #658281

    IATE #3573132
    maoirseacht frithmhiocróbán Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Antibiotic Stewardship | verantwortungsvoller Umgang mit antimikrobiellen Mitteln
    de
    Sainmhíniú organisationsweiter oder ein gesamtes Gesundheitssystem umfassender Ansatz zur Förderung und Überwachung der vernünftigen Verwendung antimikrobieller Mittel, um die zukünftige Wirksamkeit dieser Mittel zu erhalten Tagairt "Bekanntmachung der Kommission — EU-Leitlinien für die umsichtige Verwendung antimikrobieller Mittel in der Humanmedizin CELEX:52017XC0701(01)/DE"
    antimicrobial stewardship
    en
    Sainmhíniú organisational or healthcare system-wide approach to promoting and monitoring judicious use of antimicrobials to preserve their future effectiveness Tagairt "Commission notice — EU Guidelines for the prudent use of antimicrobials in human health"
    Nóta "It has three major goals:- Optimise therapy for individual patients- Prevent overuse [ IATE:3552410 ], misuse [ IATE:2251208 ] and abuse [ IATE:1494034 ] - Minimise development of resistance [ IATE:912591 ] at patient and community levels.Reference: Gov.UK. Professor Dame Sally Davies. Annual Report of the Chief Medical Officer. Volume Two, 2011 Infections and the rise of antimicrobial resistance, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/138331/CMO_Annual_Report_Volume_2_2011.pdf [9.6.2017]See also:- antimicrobial stewardship programme [ IATE:3573134 ]"
    promotion du bon usage des antimicrobiens
    fr
    Sainmhíniú démarche d’une organisation ou d’un système de soins de santé qui vise à promouvoir l’utilisation judicieuse des antimicrobiens et à en assurer un suivi afin de préserver leur efficacité ultérieure Tagairt "Lignes directrices de l'UE pour une utilisation prudente des antimicrobiens en santé humaine, CELEX:52017XC0701(01)/FR [19.7.2017]"
    Nóta "Voir aussi:- programme de promotion du bon usage des antimicrobiens [ IATE:3573134 ]"
  19. SOCIAL QUESTIONS|health|pharmaceutical industry|pharmaceutical product|medicament|antibiotic · INTERNATIONAL ORGANISATIONS|United Nations|UN specialised agency|World Health Organisation

    #668778

    IATE #3638809
    leabhar antaibheathach AWaRe de chuid na hEagraíochta Domhanda Sláinte Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Nóta <<<_not_supplied_>>>
    AWaRe-Antibiotikahandbuch der WHO | Antibiotikahandbuch der WHO „The WHO AWaRe (Access, Watch, Reserve) antibiotic book“
    de
    Sainmhíniú Handbuch der WHO für verantwortungsvollen Antibiotika-Einsatz Tagairt "COM-DE gestützt auf Dr. med. Laura Weisenburger: ""Antibiotika achtsam einsetzen, Resistenzen vermeiden"" (19.7.2023), Apotheken Umschau, 2022"
    WHO AWaRe antibiotic book
    en
    Sainmhíniú book drafted by experts and published by WHO which provides concise, evidence-based guidance on the choice of antibiotic, dose, route of administration and duration of treatment for more than 30 of the most common clinical infections in children and adults in both primary health care and hospital settings and includes summary infographics for each infection for both adults and children that provide a quick-reference guide for health care workers at the point of care Tagairt "COM-Terminology Coordination, based on: WHO. 'The WHO AWaRe (Access, Watch, Reserve) antibiotic book' (9.3.2023)"